Jonathan Schulz Selected Research

Jonathan Schulz Research Topics

5	Pneumonia (Pneumonitis) 02/2021 - 01/2020
2	Infections 04/2020 - 01/2020
2	COVID-19 04/2020 - 01/2020
1	Adenocarcinoma 01/2022
1	Adenoma (Adenomas) 01/2022
1	Colonic Neoplasms (Colon Cancer) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Proteostasis Deficiencies 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Neurofibrosarcoma (MPNST) 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 04/2020
1	Cognitive Dysfunction 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018

3	ChromatinIBA 01/2022 - 01/2021
2	Histones (Histone)IBA 01/2022 - 01/2021
2	VaccinesIBA 02/2021 - 10/2020
2	ChAdOx1 nCoV-19IBA 02/2021 - 05/2020
2	remdesivirIBA 04/2020 - 01/2020
1	Protein AggregatesIBA 01/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	Enhancer RNAsIBA 01/2022
1	HeterochromatinIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	NucleotidesIBA 01/2020
1	ProdrugsIBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2018

2	Therapeutics 04/2020 - 01/2020